Measuring and modelling the effects of systematic non-adherence to mass drug administration

by Louise Dyson, Wilma A. Stolk, Sam H. Farrell, T. Déirdre Hollingsworth
Published 2017-03-01

The effect of assortative mixing on stability of low helminth transmission levels and on the impact of mass drug administration: Model explorations for onchocerciasis.

by Anneke S de Vos, Wilma A Stolk, Sake J de Vlas, Luc E Coffeng
Published 2018-10-01

The impact of mass drug administration expansion to low onchocerciasis prevalence settings in case of connected villages.

by Anneke S de Vos, Wilma A Stolk, Luc E Coffeng, Sake J de Vlas
Published 2021-05-01

Standardisation of lymphatic filariasis microfilaraemia prevalence estimates based on different diagnostic methods: a systematic review and meta-analysis

by Natalie V. S. Vinkeles Melchers, Luc E. Coffeng, Sake J. de Vlas, Wilma A. Stolk
Published 2020-06-01

Elimination of onchocerciasis in Africa by 2025: an ambitious target requires ambitious interventions

by Robert Colebunders, Wilma A. Stolk, Joseph Nelson Siewe Fodjo, Charles D. Mackenzie, Adrian Hopkins
Published 2019-10-01

Doctors’ preferences in de-escalating DMARDs in rheumatoid arthritis: a discrete choice experiment

by T. Martijn Kuijper, Riëtte Folmer, Elly A. Stolk, Johanna M. W. Hazes, Jolanda J. Luime
Published 2017-04-01

Control, elimination, and eradication of river blindness: scenarios, timelines, and ivermectin treatment needs in Africa.

by Young Eun Kim, Jan H F Remme, Peter Steinmann, Wilma A Stolk, Jean-Baptiste Roungou, Fabrizio Tediosi
Published 2015-04-01

Correction: Control, elimination, and eradication of river blindness: scenarios, timelines, and ivermectin treatment needs in Africa.

by Young Eun Kim, Jan H F Remme, Peter Steinmann, Wilma A Stolk, Jean-Baptiste Roungou, Fabrizio Tediosi
Published 2015-05-01

Predicting lymphatic filariasis transmission and elimination dynamics using a multi-model ensemble framework

by Morgan E. Smith, Brajendra K. Singh, Michael A. Irvine, Wilma A. Stolk, Swaminathan Subramanian, T. Déirdre Hollingsworth, Edwin Michael
Published 2017-03-01

Modeling the impact and costs of semiannual mass drug administration for accelerated elimination of lymphatic filariasis.

by Wilma A Stolk, Quirine A ten Bosch, Sake J de Vlas, Peter U Fischer, Gary J Weil, Ann S Goldman
Published 2013-01-01

Elimination of African onchocerciasis: modeling the impact of increasing the frequency of ivermectin mass treatment.

by Luc E Coffeng, Wilma A Stolk, Achim Hoerauf, Dik Habbema, Roel Bakker, Adrian D Hopkins, Sake J de Vlas
Published 2014-01-01

Addressing barriers of community participation and access to mass drug administration for lymphatic filariasis elimination in Coastal Kenya using a participatory approach

by Doris W. Njomo, Lydiah W. Kibe, Bridget W. Kimani, Collins Okoyo, Wyckliff P. Omondi, Hadley M. Sultani, Wilma A. Stolk
Published 2020-09-01

Organic nitrogen in precipitation across Europe

by J. N. Cape, Y. S. Tang, J. M. González-Beníez, M. Mitošinková, U. Makkonen, M. Jocher, A. Stolk
Published 2012-11-01

Modelling Anti-Ov16 IgG4 Antibody Prevalence as an Indicator for Evaluation and Decision Making in Onchocerciasis Elimination Programmes.

by Yvonne L Lont, Luc E Coffeng, Sake J de Vlas, Allison Golden, Tala de Los Santos, Gonzalo J Domingo, Wilma A Stolk
Published 2017-01-01

Modelling the elimination of river blindness using long-term epidemiological and programmatic data from Mali and Senegal

by Martin Walker, Wilma A. Stolk, Matthew A. Dixon, Christian Bottomley, Lamine Diawara, Mamadou O. Traoré, Sake J. de Vlas, María-Gloria Basáñez
Published 2017-03-01

How does onchocerciasis-related skin and eye disease in Africa depend on cumulative exposure to infection and mass treatment?

by Natalie V S Vinkeles Melchers, Wilma A Stolk, Michele E Murdoch, Belén Pedrique, Marielle Kloek, Roel Bakker, Sake J de Vlas, Luc E Coffeng
Published 2021-06-01

Health seeking behaviour and utilization of health facilities for schistosomiasis-related symptoms in ghana.

by Anthony Danso-Appiah, Wilma A Stolk, Kwabena M Bosompem, Joseph Otchere, Caspar W N Looman, J Dik F Habbema, Sake J de Vlas
Published 2010-01-01

Between-Country Inequalities in the Neglected Tropical Disease Burden in 1990 and 2010, with Projections for 2020.

by Wilma A Stolk, Margarete C Kulik, Epke A le Rutte, Julie Jacobson, Jan Hendrik Richardus, Sake J de Vlas, Tanja A J Houweling
Published 2016-05-01

Quantifying the value of surveillance data for improving model predictions of lymphatic filariasis elimination.

by Edwin Michael, Swarnali Sharma, Morgan E Smith, Panayiota Touloupou, Federica Giardina, Joaquin M Prada, Wilma A Stolk, Deirdre Hollingsworth, Sake J de Vlas
Published 2018-10-01

The burden of skin disease and eye disease due to onchocerciasis in countries formerly under the African Programme for Onchocerciasis Control mandate for 1990, 2020, and 2030.

by Natalie V S Vinkeles Melchers, Wilma A Stolk, Welmoed van Loon, Belén Pedrique, Roel Bakker, Michele E Murdoch, Sake J de Vlas, Luc E Coffeng
Published 2021-07-01